Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis — OPEN-ISR

Coronary Stent Restenosis Clinical Trial

Official title:
OPtimal trEatment for coroNary Drug Eluting Stent In-Stent Restenosis: Paclitaxel Versus Sirolimus Coated Balloons Versus Everolimus Eluting Stents - The OPEN ISR Study

Status Recruiting

Clinical Trial Summary

The aim of this open label, randomized study is to compare the safety and efficacy of three different methods to handle coronary drug eluting stent (DES) in-stent restenosis (ISR). These are the: - Magic Touch - sirolimus coated balloon - Emperor - paclitaxel and dextran coated balloon - Xience - chromium-cobalt everolimus eluting stent

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coronary Stent Restenosis

Clinical Trial Details

NCT number	NCT04862052
Study type	Interventional
Source	Semmelweis University Heart and Vascular Center
Contact	István F Édes, MD PhD
Phone	+3614586810
Email	edes789@gmail.com
Status	Recruiting
Phase	N/A
Start date	April 14, 2021
Completion date	January 1, 2025

View Details

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT00226525` - Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation	N/A
	Terminated	`NCT00244647` - A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis	Phase 1